🇪🇺 Gamifant in European Union

Gamifant (EMAPALUMAB) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/004386
  • Local brand name: Gamifant
  • Status: refused

Gamifant in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in European Union

Frequently asked questions

Is Gamifant approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Gamifant in European Union?

Novimmune S.A. is the originator. The local marketing authorisation holder may differ — check the official source linked above.